C

Chiome Bioscience Inc
TSE:4583

Watchlist Manager
Chiome Bioscience Inc
TSE:4583
Watchlist
Price: 180 JPY 20% Market Closed
Market Cap: 11.2B JPY
Have any thoughts about
Chiome Bioscience Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Chiome Bioscience Inc

Rotate your device to view
Cash Flow Statement
Currency: JPY
Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Mar-2014 Sep-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Operating Cash Flow
Net Income
(153)
(220)
(284)
(425)
(507)
(517)
(743)
(1 009)
(886)
(1 587)
(1 281)
(1 289)
(1 501)
(1 180)
(880)
(1 095)
(1 531)
(1 684)
(1 401)
(1 380)
(1 291)
(953)
(1 466)
(1 838)
(1 238)
(1 131)
(1 215)
(1 116)
Depreciation & Amortization
69
54
53
55
61
64
73
92
81
151
102
113
113
62
11
9
7
6
5
4
4
3
3
2
1
1
1
1
Other Non-Cash Items
33
32
2
4
16
4
(2)
(1)
19
22
27
155
435
0
0
0
0
0
0
0
0
0
150
0
0
0
0
(20)
Cash Taxes Paid
4
2
2
2
2
2
2
3
3
4
1
4
4
2
2
2
2
2
2
2
2
(5)
(5)
3
3
5
5
5
Cash Interest Paid
2
2
2
2
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
2
2
2
Change in Working Capital
(103)
17
(47)
(8)
1
9
120
111
(3)
(104)
(11)
43
(17)
27
2
(86)
(165)
2
(141)
(12)
(73)
(443)
182
455
45
3
145
(17)
Cash from Operating Activities
(155)
N/A
(117)
+24%
(277)
-136%
(373)
-35%
(429)
-15%
(440)
-3%
(552)
-26%
(806)
-46%
(789)
+2%
(1 518)
-92%
(1 162)
+23%
(1 003)
+14%
(970)
+3%
(786)
+19%
(867)
-10%
(1 172)
-35%
(1 689)
-44%
(1 676)
+1%
(1 537)
+8%
(1 388)
+10%
(1 360)
+2%
(1 393)
-2%
(1 131)
+19%
(1 231)
-9%
(1 191)
+3%
(1 126)
+5%
(1 069)
+5%
(1 151)
-8%
Investing Cash Flow
Capital Expenditures
(24)
(44)
(43)
(43)
(187)
(192)
(279)
(176)
(119)
(187)
(168)
(106)
(11)
(10)
(5)
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Items
(0)
0
(36)
(72)
(72)
(70)
90
88
(500)
(2 197)
(1 612)
1 985
2 000
(50)
(132)
0
0
0
(26)
0
(4)
0
(35)
0
0
0
0
0
Cash from Investing Activities
(24)
N/A
(44)
-82%
(79)
-82%
(115)
-45%
(259)
-125%
(261)
-1%
(189)
+28%
(88)
+54%
(619)
-604%
(2 384)
-285%
(1 780)
+25%
1 879
N/A
1 989
+6%
(60)
N/A
(137)
-129%
0
N/A
0
N/A
0
N/A
(26)
N/A
0
N/A
(4)
N/A
0
N/A
(35)
N/A
0
N/A
0
N/A
0
N/A
0
+111%
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
507
504
45
366
3 809
3 806
4 200
884
2 152
2 172
21
178
1 461
1 814
529
0
0
1 250
1 346
793
1 770
1 239
254
424
1 126
0
555
1 009
Net Issuance of Debt
(8)
65
54
48
(8)
(111)
(111)
(58)
(21)
0
100
75
(46)
(50)
(50)
(25)
(4)
0
0
199
180
(9)
3
(2)
1
110
107
(6)
Other
0
0
(10)
49
0
49
14
0
0
0
4
0
18
0
0
0
(6)
(7)
(4)
(5)
(6)
0
15
0
(0)
(1)
6
0
Cash from Financing Activities
468
N/A
539
+15%
88
-84%
463
+425%
3 850
+731%
3 744
-3%
4 103
+10%
840
-80%
2 131
+154%
2 151
+1%
124
-94%
256
+106%
1 434
+460%
1 782
+24%
479
-73%
(26)
N/A
(10)
+61%
1 242
N/A
1 341
+8%
987
-26%
1 944
+97%
1 225
-37%
271
-78%
436
+61%
1 127
+158%
899
-20%
667
-26%
1 009
+51%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
(0)
1
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
290
N/A
378
+31%
(268)
N/A
(25)
+91%
3 163
N/A
3 043
-4%
3 361
+10%
(52)
N/A
726
N/A
(1 748)
N/A
(2 818)
-61%
1 132
N/A
2 453
+117%
936
-62%
(526)
N/A
(1 180)
-124%
(1 699)
-44%
(433)
+74%
(223)
+49%
(427)
-92%
580
N/A
(171)
N/A
(895)
-424%
(830)
+7%
(64)
+92%
(227)
-255%
(402)
-77%
(142)
+65%
Free Cash Flow
Free Cash Flow
(179)
N/A
(161)
+10%
(320)
-99%
(416)
-30%
(615)
-48%
(632)
-3%
(832)
-32%
(981)
-18%
(908)
+7%
(1 705)
-88%
(1 330)
+22%
(1 109)
+17%
(981)
+12%
(796)
+19%
(872)
-10%
(1 172)
-34%
(1 689)
-44%
(1 676)
+1%
(1 537)
+8%
(1 388)
+10%
(1 360)
+2%
(1 393)
-2%
(1 131)
+19%
(1 231)
-9%
(1 191)
+3%
(1 126)
+5%
(1 069)
+5%
(1 151)
-8%

See Also

Discover More